USPTO serial 77623859
WE BELIEVE THE POSSIBILITIES
Reviewed by CopyMark Law Group
Reg. 4043656Status 710
- Filing date
- Status date
- Registration date
- Oct 25, 2011
- Examiner
- MAI, TINA HSIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with WE BELIEVE THE POSSIBILITIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas L. Holt
THOMAS L. HOLT BRINKS HOFER GILSON & LIONEPO BOX 10395CHICAGO, IL 60610-0395UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents other than for medical or veterinary purposes; chemical preparations for scientific purposes, including non-therapeutic ingredients used in pharmaceutical manufacture; diagnostic chemicals for scientific or research use; diagnostic reagents and diagnostic preparations, other than for medical or veterinary purposes; reagents for hematology analysis for scientific or research use; reagents for reticulocyte analysis for scientific or research use; reagents for blood coagulation analysis for scientific or research use; reagents for urinalysis for scientific or research use; reagents for immunoassay for scientific or research use; reagents for clinical chemistry testing for scientific or research use; reagents for occult blood test for scientific or research use; reagents for gene test for scientific or research use; lysing solutions or reagents for scientific or research use; hemolytic lysing solutions or reagents for scientific or research use; chemical reagent stains for industrial use; chemicals, namely, sheath solutions for industrial use; reference control chemicals for industrial use; chemical reference materials for industrial use; quality control standard solutions and quality control chemicals for industrial use for testing and calibrating medical apparatus and reagents; hematology control chemicals for testing and calibrating medical apparatus and reagents; hematology control chemicals for industrial use; standard serum for scientific or research use; control serum for scientific or research use; biochemical standard serum for scientific or research use; biochemical control serum for scientific or research use; quality control standard solutions and quality control chemicals for testing and calibrating medical apparatus and reagents; stains for medical or clinical laboratory use; stains for hematology analysis for medical or clinical laboratory use; stains for reticulocyte analysis for medical or clinical laboratory use; stains for urinalysis for medical or clinical laboratory use; stains for immunoassay for medical or clinical laboratory use | SECTION 8 - CANCELLED | — |
| 003 | Cleaning solutions for apparatus and instruments; cleaning preparations for industrial use; cleansing solutions for apparatus and instruments; cleaning solutions for apparatus and instruments for medical purposes; cleaning preparations for apparatus and instruments for medical purposes; cleansing solutions for apparatus and instruments for medical purposes; detergents for apparatus and instruments | SECTION 8 - CANCELLED | — |
| 005 | Sanitary preparations for medical use; diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; testing reagents for medical or clinical use; reagents for hematology analysis for medical or clinical use; reagents for blood analysis for medical or clinical use; reagents for white blood cell analysis for medical or clinical use; reagents for immature cell analysis for medical or clinical use; reagents for hemoglobin analysis for medical or clinical use; reagents for reticulocyte analysis for medical or clinical use; reagents for erythrocyte analysis for medical or clinical use; reagents for nucleated red cell analysis for medical or clinical use; reagents for blood coagulation analysis for medical or veterinary purposes; reagents for urinalysis for medical or veterinary purposes; reagents for urinary sediment analysis for medical or veterinary purposes; reagents for immunoassay for medical or veterinary purposes; reagents for bacteria analysis for medical or veterinary purposes; reagents for clinical chemistry testing for medical or veterinary purposes; reagents for occult blood test for medical or veterinary purposes; reagents for genetic test for medical or veterinary purposes; reagents for protein test for medical or veterinary purposes; reagents for cancer recurrence prediction test for medical or veterinary purposes; reagents for anticancer drug sensitivity prediction test for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for hematology analysis for medical or veterinary purposes; diluents for reticulocyte analysis for medical or veterinary purposes; diluents for urinalysis for medical or veterinary purposes; diluents for immunoassay for medical or veterinary purposes; medical diagnostic reagents and solutions, namely, lysing solutions and reagents and hemolytic lysing solutions and reagents; medical diagnostic reagents and solutions, namely, sheath solutions; hematology control reagents for medical use; reference control reagents for medical use | SECTION 8 - CANCELLED | — |
| 009 | Particle analyzers; particle image analyzers; particle counters; particle size distribution analyzers; bacteria analyzers; test tubes and holders therefore; pipettes; data processing apparatus for use in the field of medical, clinical, diagnostic or laboratory analysis; data processing apparatus for use in the field of hematology analysis or diagnosis; data processing apparatus for use in the field of analysis or diagnosis of bodily fluids, urine or cells; data processing apparatus for use in industries; data processing apparatus for use in measurement of particles and powders; computers; computer peripheral devices; printers for use with computer; computer keyboards; computer memories; computer software for use in the field of medical, clinical, diagnostic or laboratory analysis; computer software for use in the field of hematology analysis or diagnosis; computer software for use in the field of analysis or diagnosis of bodily fluids, urine or cells; computer software for use in measurement of particles and powders; computer software for gathering, processing, storing and supplying data in the field of medical, clinical, or laboratory analysis and diagnosis, and for managing such data; computer software for gathering, processing, storing and supplying data for use in industries, and for managing such data; computer program for use in the field of medical, clinical, diagnostic or laboratory analysis; computer program for use in the field of hematology analysis or diagnosis; computer program for use in the field of analysis or diagnosis of bodily fluids, urine or cells; computer program for use in measurement of particles and powders; computer program for gathering, processing, storing and supplying data in the field of medical, clinical, or laboratory analysis and diagnosis, and for managing such data; computer program for gathering, processing, storing and supplying data for use in industries, and for managing such data; computer operating programs, recorded for use in the field of medical, clinical, diagnostic or laboratory analysis; computer operating programs, recorded for use in the field of hematology analysis or diagnosis; computer operating programs, recorded for use in the field of analysis or diagnosis of bodily fluids, urine or cells; computer operating programs, recorded for use in industries; computer operating programs, recorded for use in measurement of particles and powders; computer operating programs, recorded for gathering, processing, storing and supplying data in the field of medical, clinical, or laboratory analysis and diagnosis, and for managing such data; computer operating programs, recorded for gathering, processing, storing and supplying data for use in industries, and for managing such data; couplers for data processing equipment; optical readers for data processing; magnetic tape units for computers; pre-recorded magnetic data media featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded magnetic computer tapes featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded video discs and video tapes featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded optical data media featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded optical discs featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded compact discs featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; pre-recorded data compact discs featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; encoded cards, magnetic; exposed cinematographic films; exposed slide films; slide film mounts; downloadable image files featuring information on medical, clinical, scientific, diagnostic or research analysis techniques; downloadable electronic publications, namely, book and magazine featuring on medical, clinical, scientific, diagnostic or research analysis techniques; integrated circuits; microscope slides; laboratory beakers; plastic cups for laboratory use; test tubes for microbiological purposes; test tubes for immunological purposes; infrared spectroscopic analyzing apparatus and instruments; immunochemical analyzing apparatus and instruments; immunological testing apparatus and instruments; immunoassay apparatus and instruments; apparatus and instruments for clinical chemistry analyzing; occult blood analyzing apparatus and instruments; bacteria analyzing apparatus and instruments; genetic testing apparatus and instruments; gene amplification analyzer; diluting apparatus and instruments; pipettes for medical purposes; disposable beakers; beaker stands; test tube stands; slides for medical purposes; structural parts and fittings for all the aforementioned goods | SECTION 8 - CANCELLED | — |
| 010 | Diagnostic or measuring apparatus and instruments for medical purposes, namely, hematological analyzing apparatus and instruments, blood cell analyzers, reticulocyte analyzing apparatus and instruments, erythrocyte analyzing apparatus and instruments, blood coagulation analyzing apparatus and instruments, platelet aggregation analyzing apparatus and instruments, blood pretreatment apparatus and instruments, non-invasive blood analyzing apparatus and instruments, non-invasive blood vessel monitor, cell counters, blood cell counters, platelet counters, particle counters for medical purposes, urinalysis apparatus and instruments, urine cell analyzing apparatus and instruments, urinary particle analyzing apparatus and instruments, urine pretreatment apparatus and instruments, cancer lymphatic metastasis analyzer, blood collecting devices, blood sampling tubes, needles for medical purposes, smear test sample making apparatus and instruments, aspirators for medical purposes, sphygmomanometers, blood collecting tubes, and medical containers, namely, containers for samples for in vitro diagnosis, sampling bottles, and disposable cups for urinalysis; structural parts and fittings for all the aforementioned goods | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named WE BELIEVE THE POSSIBILITIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 25, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 25, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 9, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 5, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 2, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 2, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 2, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 2, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 2, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 24, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 27, 2010 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 15, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 9, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 9, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 4, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 29, 2010 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 15, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 13, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2010 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 1, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2008 | NWAP | NEW APPLICATION ENTERED | — |